InfanDx tackles early detection of hypoxic ischemic encephalopathy
InfanDX is developing its HypoxE blood test for the early detection of hypoxic ischemic encephalopathy (HIE).
Source: labiotech.eu
Stay updated with breaking news from Hypoxe Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
InfanDX is developing its HypoxE blood test for the early detection of hypoxic ischemic encephalopathy (HIE).
Clinical data curation and evaluation ongoingFollow-up rate of 77% fully meets expectations (70-80%) Final HIE biomarker panel validation data expected by...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.